[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 28, 1996

Results of Radical Prostatectomy in Men With Clinically Localized Prostate CancerMulti-institutional Pooled Analysis

Author Affiliations

From the Section of Urology, Department of Surgery (Drs Gerber, Rukstalis, and Chodak), and the Departments of Statistics and Anesthesia and Critical Care (Dr Thisted), and the Cancer Research Center (Dr Thisted), University of Chicago (III) Pritzker School of Medicine; Department of Urology, Baylor College of Medicine, Houston, Tex (Drs Scardino and Ohori); Department of Urology, University of Würzburg (Germany) (Dr Frohmuller); Institute of Urology, Erasmus University, Rotterdam, the Netherlands (Dr Schroeder); Division of Urology, Department of Surgery, Duke University School of Medicine, Durham, NC (Dr Paulson); Department of Urology, University of Utah School of Medicine, Salt Lake City (Dr Middleton); Department of Urology, Vanderbilt University School of Medicine, Nashville, Tenn (Dr Smith); and Department of Urology, Eastern Virginia Medical School, Norfolk (Dr Schellhammer).

JAMA. 1996;276(8):615-619. doi:10.1001/jama.1996.03540080037026
Abstract

Objective.  —To assess the results of radical prostatectomy in men with early prostate cancer.

Design.  —Retrospective, nonrandomized, multi-institutional pooled analysis.

Setting.  —Eight university medical centers in the United States and Europe.

Patients.  —A total of 2758 men with stage T1 and T2 prostatic cancer.

Main Outcome Measures.  —Disease-specific and metastasis-free survival rates.

Results.  —Tumor grade was the most important preoperative factor in determining outcome. Disease-specific survival 10 years following surgery and associated 95% confidence intervals were 94% (range, 87%-98%), 80% (range, 74%-85%), and 77% (range, 65%-86%) for those men with grade 1, 2, and 3 tumors, respectively. Metastasis-free survival at 10 years was 87% (range, 78%-92%), 68% (range, 62%-73%), and 52% (range, 38%-64%) for patients with grade 1, 2, and 3 cancers, respectively.

Conclusions.  —Radical prostatectomy leads to high 10-year disease-specific survival rates in men with all tumor grades. However, caution is needed in comparing these results with similar studies of alternative treatment strategies, such as watchful waiting, due to the inherent potential biases in uncontrolled trials. Nevertheless, these results offer the best currently available estimates of 10-year outcome of radical prostatectomy in men with clinically localized prostate cancer and may be useful in counseling patients with early malignancy.

×